<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/96BFFAB5-69B1-49E8-8F41-9C763818EFA6"><gtr:id>96BFFAB5-69B1-49E8-8F41-9C763818EFA6</gtr:id><gtr:name>Jaguar Land Rover</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE3B711-DED5-4EB0-AC1A-EE27FEA92600"><gtr:id>5EE3B711-DED5-4EB0-AC1A-EE27FEA92600</gtr:id><gtr:name>ParAid Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/748D2A26-0784-489D-A34F-06E6569F5EAF"><gtr:id>748D2A26-0784-489D-A34F-06E6569F5EAF</gtr:id><gtr:name>Sightlife</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/96BFFAB5-69B1-49E8-8F41-9C763818EFA6"><gtr:id>96BFFAB5-69B1-49E8-8F41-9C763818EFA6</gtr:id><gtr:name>Jaguar Land Rover</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE3B711-DED5-4EB0-AC1A-EE27FEA92600"><gtr:id>5EE3B711-DED5-4EB0-AC1A-EE27FEA92600</gtr:id><gtr:name>ParAid Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/748D2A26-0784-489D-A34F-06E6569F5EAF"><gtr:id>748D2A26-0784-489D-A34F-06E6569F5EAF</gtr:id><gtr:name>Sightlife</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9F5AA990-DB5B-4D48-A28A-839EF6E891AD"><gtr:id>9F5AA990-DB5B-4D48-A28A-839EF6E891AD</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Masterman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_14102"><gtr:id>F56776DA-BB59-452F-B813-87B56649C599</gtr:id><gtr:title>Establishing the potential for healthcare benefits arising from novel biomedical research
concepts and discoveries at The University of Nottingham</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_14102</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The Confidence in Concept scheme is a key part of MRC?s translational research strategy and provides annual awards to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. The award can be used by the institution to support a number of preliminary-stage translational projects. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach ?? before seeking more substantive funding.&amp;nbsp; It is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>600000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Jaguar Land Rover</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Don Sharkey: Jaguar Land Rover</gtr:description><gtr:id>AEDBECD4-CF7E-4E68-A6FC-D20C8427C961</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58bff04382ea32.62408469-1</gtr:outcomeId><gtr:partnerContribution>Transport knowledge and safety</gtr:partnerContribution><gtr:piContribution>Design and development of a novel neonatal transport system</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ParAid Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Don Sharkey: Innovate UK Knowledge Transfer Partnership awarded with industrial partner ParAid</gtr:description><gtr:id>5B58EC6C-DBC7-4200-BA42-B0198B0C479D</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58bfefb4424d55.97441484-1</gtr:outcomeId><gtr:partnerContribution>Market and regulatory knowledge</gtr:partnerContribution><gtr:piContribution>Development of a novel neonatal transport system</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sightlife</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Theagen as an exciting future sight saving therapy</gtr:description><gtr:id>58E9551D-700D-47A2-A758-0D349D90103A</gtr:id><gtr:impact>No outputs to date.</gtr:impact><gtr:outcomeId>56cb1e93d19d62.27601962-1</gtr:outcomeId><gtr:partnerContribution>Sightlife is the world's largest not-for-profit corneal transplant distribution organisation and will provide research corneas to aid the development of new corneal therapies from the department of Academic Opthalmology.</gtr:partnerContribution><gtr:piContribution>Research into potential new therapies for corneal repair and transplantation.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>151000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovate UK feasibility project</gtr:description><gtr:fundingOrg>Innovate UK</gtr:fundingOrg><gtr:id>78645D36-2643-4673-B5ED-D8846A851883</gtr:id><gtr:outcomeId>56cb06f1c07380.15837326</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>81000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dr Don Sharkey: EPSRC iCase award with Jaguar Land Rover</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>3F59B6B6-F41E-48CF-873C-BC4839056EBE</gtr:id><gtr:outcomeId>58bfee8a631991.04917331</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>102000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovate UK KTP</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Innovate UK</gtr:fundingOrg><gtr:id>E0C2782E-18C4-4F36-93DB-97E86ECA94BA</gtr:id><gtr:outcomeId>56cb08cabaf4d6.56976000</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Pathfinder</gtr:description><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>B9CDF3DB-57A9-45D0-A217-66FD743D8B0E</gtr:id><gtr:outcomeId>56cb08685c89e3.97052151</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>97000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Impact Acceleration Award</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>A1ACCC1A-1985-4D69-BF9D-D5B107CC4F6F</gtr:id><gtr:outcomeId>56cb0810928aa6.93961642</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Nottingham City Council Technology Grant Fund 'N'Tech'</gtr:description><gtr:fundingOrg>Nottingham City Council</gtr:fundingOrg><gtr:id>7C9FC91C-0826-437C-8F81-8A2E8752396E</gtr:id><gtr:outcomeId>56cb0691a9b446.01074488</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovate UK SMART Proof of Market</gtr:description><gtr:fundingOrg>Innovate UK</gtr:fundingOrg><gtr:id>83266E0C-6664-4774-ACFB-39A7070A0980</gtr:id><gtr:outcomeId>56cb0609c66b92.81936940</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>52000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dr Don Sharkey: Innovate UK Knowledge Transfer Partnership awarded with industrial partner ParAid</gtr:description><gtr:fundingOrg>Innovate UK</gtr:fundingOrg><gtr:id>D45C4AAF-5453-43F9-84DD-F7E6EB67F694</gtr:id><gtr:outcomeId>58bfeefd330b59.63123484</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>877000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR i4i Invention for Innovation (i4i) Programme</gtr:department><gtr:description>NIHR Invention for Innovation 'i4i'</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C6E44353-CD2B-489A-AFC6-688F53F3B6E1</gtr:id><gtr:outcomeId>56cb0933d480c3.46632040</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>107623</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dr Hadwen Trust Research Grant</gtr:description><gtr:fundingOrg>Dr Hadwen Trust (DHT)</gtr:fundingOrg><gtr:id>5BF34484-A27E-4DE9-9B38-F02614745211</gtr:id><gtr:outcomeId>56cb05b0dd9dc1.19985153</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>NuVision Biotherapies Ltd</gtr:companyName><gtr:description>NuVision? is a spin-out company from the University of Nottingham, incorporated July 2014. The company was established to commercialise high quality and affordable biotherapies for treating 'front of the eye' disease and trauma.</gtr:description><gtr:id>58335BF6-5D29-49DE-93E1-EA7421A14E77</gtr:id><gtr:impact>Mercia Fund Management has provided &amp;pound;379,000 in seed funding to help NuVision commercialise its ground-breaking product.</gtr:impact><gtr:outcomeId>56cb1c5225c6b2.39675852</gtr:outcomeId><gtr:url>http://www.nu-vision.co.uk/</gtr:url><gtr:yearCompanyFormed>2015</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>23932E89-C245-40AF-B640-8E48B7C51B10</gtr:id><gtr:title>Multiparametric Renal Magnetic Resonance Imaging: Validation, Interventions, and Alterations in Chronic Kidney Disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/864df1b3c8fe3c9e43f875b60147788d"><gtr:id>864df1b3c8fe3c9e43f875b60147788d</gtr:id><gtr:otherNames>Cox EF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-042X</gtr:issn><gtr:outcomeId>5a8c04c879e8a7.91403077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C862B5D-AAFC-450F-A149-6179BEE2CFB7</gtr:id><gtr:title>Fixational eye movements predict visual sensitivity.</gtr:title><gtr:parentPublicationTitle>Proceedings. Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da4be31eb2f0f81b95e5d084ab0977ca"><gtr:id>da4be31eb2f0f81b95e5d084ab0977ca</gtr:id><gtr:otherNames>Scholes C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8452</gtr:issn><gtr:outcomeId>58bfed5e2fb941.90019337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D89F88EC-F28D-4027-AD50-93DC27D5DB90</gtr:id><gtr:title>Imaging the kidney using magnetic resonance techniques: structure to function.</gtr:title><gtr:parentPublicationTitle>Current opinion in nephrology and hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe934b3cba07b0eada5c23a624fa5dff"><gtr:id>fe934b3cba07b0eada5c23a624fa5dff</gtr:id><gtr:otherNames>Mahmoud H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1062-4821</gtr:issn><gtr:outcomeId>58bfebde2ff443.47679219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71F51F85-6E35-48F4-B738-5CC09E758FB8</gtr:id><gtr:title>Corneal Decellularization: A Method of Recycling Unsuitable Donor Tissue for Clinical Translation?</gtr:title><gtr:parentPublicationTitle>Current eye research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ea8c72639436b3b4cb51f7d009086b3"><gtr:id>5ea8c72639436b3b4cb51f7d009086b3</gtr:id><gtr:otherNames>Wilson SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0271-3683</gtr:issn><gtr:outcomeId>56cb2137a952e5.62854962</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>418563E9-2D95-4BD9-9CE4-28A3E0E0EFB5</gtr:id><gtr:title>Neonatal head and torso vibration exposure during inter-hospital transfer.</gtr:title><gtr:parentPublicationTitle>Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbcca139fa887763c29e906b49264775"><gtr:id>cbcca139fa887763c29e906b49264775</gtr:id><gtr:otherNames>Blaxter L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0954-4119</gtr:issn><gtr:outcomeId>58bfec99270cb0.39959849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>399BC93D-2621-471C-86E6-010B3B866406</gtr:id><gtr:title>Quantitative analysis of the z-spectrum using a numerically simulated look-up table: Application to the healthy human brain at 7T.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1faf4137e58b25e46c0f40dc70de92a7"><gtr:id>1faf4137e58b25e46c0f40dc70de92a7</gtr:id><gtr:otherNames>Geades N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>58bfece449a727.02847466</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_14102</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C4255A20-7C03-4147-BA26-8D72C9457F1C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Health Uncodeable</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>06E85C67-BEDD-4C93-990D-B74FCF876924</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>HRCS Research Uncodeable</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>